Literature DB >> 12893279

Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1.

Judit Hargitai1, Hannah Lewis, Imre Boros, Tímea Rácz, András Fiser, István Kurucz, Ivor Benjamin, László Vígh, Zoltán Pénzes, Péter Csermely, David S Latchman.   

Abstract

The novel hydroxylamine derivative, bimoclomol, has been shown previously to act as a co-inducer of several heat shock proteins (Hsp-s), enhancing the amount of these proteins produced following a heat shock compared to heat shock alone. Here we show that the co-inducing effect of bimoclomol on Hsp expression is mediated via the prolonged activation of the heat shock transcription factor (HSF-1). Bimoclomol effects are abolished in cells from mice lacking HSF-1. Moreover, bimoclomol binds to HSF-1 and induces a prolonged binding of HSF-1 to the respective DNA elements. Since HSF-1 does not bind to DNA in the absence of stress, the bimoclomol-induced extension of HSF-1/DNA interaction may contribute to the chaperone co-induction of bimoclomol observed previously. These findings indicate that bimoclomol may be of value in targeting HSF-1 so as to induce up-regulation of protective Hsp-s in a non-stressful manner and for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893279     DOI: 10.1016/s0006-291x(03)01254-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Induction of heat shock proteins by hyperthermia and noise overstimulation in hsf1 -/- mice.

Authors:  Tzy-Wen Gong; Damon A Fairfield; Lynne Fullarton; David F Dolan; Richard A Altschuler; David C Kohrman; Margaret I Lomax
Journal:  J Assoc Res Otolaryngol       Date:  2011-09-20

Review 2.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 3.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

Review 4.  Heat shock proteins as emerging therapeutic targets.

Authors:  Csaba Sõti; Enikõ Nagy; Zoltán Giricz; László Vígh; Péter Csermely; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 5.  [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].

Authors:  K Kollewe; R Dengler; S Petri
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

6.  Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol.

Authors:  Catherine A S Deane; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2016-06-08       Impact factor: 3.667

7.  Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome.

Authors:  Zohar Bromberg; Nichelle Raj; Pierre Goloubinoff; Clifford S Deutschman; Yoram G Weiss
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 8.  The Role of the Protein Quality Control System in SBMA.

Authors:  Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Carlo Rinaldi; Maria Elena Cicardi; Mariarita Galbiati; Serena Carra; Bilal Malik; Linda Greensmith; Angelo Poletti
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 9.  Heat shock proteins in diabetes and wound healing.

Authors:  Mustafa Atalay; Niku Oksala; Jani Lappalainen; David E Laaksonen; Chandan K Sen; Sashwati Roy
Journal:  Curr Protein Pept Sci       Date:  2009-02       Impact factor: 3.272

Review 10.  Small molecule activators of the heat shock response and neuroprotection from stroke.

Authors:  Donald B DeFranco; Louisa Ho; Eric Falke; Clifton W Callaway
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.